Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders
The effector functions of T lymphocytes are responsible for most autoimmune disorders and act by directly damaging tissues or by indirectly promoting inflammation and antibody responses. Co-stimulatory and co-inhibitory T cell receptor molecules are the primary pharmacological targets that enable in...
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
MDPI AG
2017-11-01
|
| Collection: | Antibodies |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2073-4468/6/4/19 |